Evaxion - Debt to Equity Ratio 2020-2025 | EVAX

Current and historical debt to equity ratio values for Evaxion - (EVAX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Evaxion - debt/equity for the three months ending March 31, 2025 was 0.00.
Evaxion - Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2025-03-31 $0.02B $0.01B 1.44
2024-09-30 $0.00B 0.00
2024-06-30 $0.01B $0.00B 11.16
2023-06-30 $0.01B $0.00B 5.61
2022-06-30 $0.01B $0.02B 0.69
2022-03-31 $0.02B $0.03B 0.56
2021-12-31 $0.01B $0.03B 0.24
2021-09-30 $0.01B $0.02B 0.45
2021-06-30 $0.01B $0.02B 0.27
2021-03-31 $0.01B $0.03B 0.26
2020-12-31 $0.01B $0.01B 0.70
2020-09-30 $0.00B $0.00B 0.00
2020-06-30 $0.00B $0.00B 0.00
2020-03-31 $0.00B $0.00B 0.00
2019-12-31 $0.00B $0.01B 0.18
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.003B $0.003B
Evaxion A/S is a clinical-stage TechBio company specializing in developing AI-Immunology(TM) powered vaccines. Evaxion A/S, formerly known as Evaxion Biotech A/S, is based in COPENHAGEN, Denmark.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.064B 58.60
Hims & Hers Health (HIMS) United States $13.260B 137.77
Tempus AI (TEM) United States $12.137B 0.00
IRhythm Technologies (IRTC) United States $4.628B 0.00
Inspire Medical Systems (INSP) United States $3.753B 58.64
Hinge Health (HNGE) United States $2.965B 0.00
Privia Health (PRVA) United States $2.730B 186.58
Enovis (ENOV) United States $1.764B 9.83
Schrodinger (SDGR) United States $1.532B 0.00
Phreesia (PHR) United States $1.519B 0.00
Clover Health Investments (CLOV) United States $1.440B 0.00
Azenta (AZTA) United States $1.342B 62.36
Omnicell (OMCL) United States $1.335B 23.55
10x Genomics (TXG) United States $1.300B 0.00
Claritev (CTEV) United States $0.661B 0.00
Fulgent Genetics (FLGT) United States $0.617B 0.00
Butterfly Network (BFLY) United States $0.544B 0.00
Talkspace (TALK) United States $0.477B 142.50
Veradigm (MDRX) United States $0.476B 0.00
Standard BioTools (LAB) United States $0.387B 0.00
TruBridge (TBRG) United States $0.348B 771.33
Outset Medical (OM) United States $0.336B 0.00
Health Catalyst (HCAT) United States $0.265B 0.00
Nyxoah SA (NYXH) Belgium $0.264B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.195B 0.00
KORU Medical Systems (KRMD) United States $0.150B 0.00
EUDA Health Holdings (EUDA) Singapore $0.134B 0.00
Pulmonx (LUNG) United States $0.109B 0.00
American Well (AMWL) United States $0.104B 0.00
CareCloud (CCLD) United States $0.099B 3.79
MDxHealth SA (MDXH) Belgium $0.093B 0.00
111 (YI) China $0.071B 0.00
HeartBeam (BEAT) United States $0.052B 0.00
P3 Health Partners (PIII) United States $0.045B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.043B 0.00
Zepp Health (ZEPP) Netherlands $0.033B 0.00
Zhongchao (ZCMD) China $0.033B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.001B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00